|
FDA approves new treatment for patients with migraine
|
11 October 2019 |
|
FDA awards 12 grants to fund new clinical trials to advance the development of medical products for the treatment of rare diseases
|
08 October 2019 |
|
FDA approves second drug to prevent HIV infection as part of ongoing efforts to end the HIV epidemic
|
03 October 2019 |
|
FDA announces voluntary recall of Sandoz ranitidine capsules following detection of an impurity
|
24 September 2019 |
|
FDA approves first oral GLP-1 treatment for type 2 diabetes
|
20 September 2019 |
|
FDA takes first action under new international collaboration with Australia and Canada
|
17 September 2019 |
|
FDA approves first treatment for patients with rare type of lung disease
|
09 September 2019 |
|
FDA approves new drug for treatment-resistant forms of tuberculosis that affects the lungs
|
15 August 2019 |
|
FDA approves first therapy for rare joint tumor
|
02 August 2019 |
|
FDA approves first treatment for severe hypoglycemia that can be administered without an injection
|
25 July 2019 |
|
FDA approves first generics of Lyrica
|
22 July 2019 |
|
FDA approves new treatment for refractory multiple myeloma
|
03 July 2019 |
|
FDA approves first treatment for neuromyelitis optica spectrum disorder, a rare autoimmune disease of the central nervous system
|
27 June 2019 |
|
FDA seeks public feedback on new drug approval transparency efforts
|
26 June 2019 |
|
FDA approves first chemoimmunotherapy regimen for patients with relapsed or refractory diffuse large B-cell lymphoma
|
10 June 2019 |
|
FDA announces Project Facilitate to assist physicians seeking access to unapproved therapies for patients with cancer
|
03 June 2019 |
|
FDA approves first anticoagulant (blood thinner) for pediatric patients to treat potentially life-threatening blood clots
|
16 May 2019 |
|
FDA approves first treatment for children with Lambert-Eaton myasthenic syndrome
|
09 May 2019 |
|
FDA approves new treatments for heart disease caused by a serious rare disease, transthyretin mediated amyloidosis
|
06 May 2019 |
|
FDA approves first treatment for pediatric patients with lupus
|
26 April 2019 |